Amoeba SA (ALMIB) - Total Assets
Based on the latest financial reports, Amoeba SA (ALMIB) holds total assets worth €10.13 Million EUR (≈ $11.85 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Amoeba SA - Total Assets Trend (2011–2025)
This chart illustrates how Amoeba SA's total assets have evolved over time, based on quarterly financial data. Also see Amoeba SA stock valuation for the company's overall valuation and market capitalisation.
Amoeba SA - Asset Composition Analysis
Current Asset Composition (December 2025)
Amoeba SA's total assets of €10.13 Million consist of 66.2% current assets and 33.8% non-current assets. Review ALMIB total debt and obligations to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 46.6% |
| Accounts Receivable | €1.21 Million | 11.9% |
| Inventory | €590.48K | 5.8% |
| Property, Plant & Equipment | €3.32 Million | 32.7% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2011–2025)
This chart illustrates how Amoeba SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Amoeba SA (ALMIB) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Amoeba SA's current assets represent 66.2% of total assets in 2025, an increase from 41.7% in 2011.
- Cash Position: Cash and equivalents constituted 46.6% of total assets in 2025, up from 27.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 33.0% in 2011.
- Asset Diversification: The largest asset category is property, plant & equipment at 32.7% of total assets.
Amoeba SA Competitors by Total Assets
Key competitors of Amoeba SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Qinghai Salt Lake Industry Co.Ltd
SHE:000792
|
China | CN¥61.57 Billion |
|
Shaanxi Meibang Pharmaceutical Group Co Ltd
SHG:605033
|
China | CN¥1.91 Billion |
|
Boa Safra Sementes S.A
SA:SOJA3
|
Brazil | R$4.01 Billion |
|
Soquicom
SN:SOQUICOM
|
Chile | CL$133.30 Million |
|
Verde Agritech PLC
TO:NPK
|
Canada | CA$76.90 Million |
|
EMMERSON PLC O.N.
F:4UM
|
Germany | €1.69 Million |
|
Terragen Holdings Ltd
AU:TGH
|
Australia | AU$5.84 Million |
|
Neurizer Ltd
AU:NRZ
|
Australia | AU$132.63 Million |
Amoeba SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 0.42 | 2.97 |
| Quick Ratio | 0.89 | 0.37 | 2.92 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-142.34K | €-3.02 Million | €4.12 Million |
Amoeba SA - Advanced Valuation Insights
This section examines the relationship between Amoeba SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.00 |
| Latest Market Cap to Assets Ratio | 4.49 |
| Asset Growth Rate (YoY) | 79.3% |
| Total Assets | €10.13 Million |
| Market Capitalization | $45.47 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Amoeba SA's assets at a significant premium (4.49x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Amoeba SA's assets grew by 79.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Amoeba SA (2011–2025)
The table below shows the annual total assets of Amoeba SA from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €10.13 Million ≈ $11.85 Million |
+79.29% |
| 2024-12-31 | €5.65 Million ≈ $6.61 Million |
-10.11% |
| 2023-12-31 | €6.29 Million ≈ $7.35 Million |
-49.27% |
| 2022-12-31 | €12.39 Million ≈ $14.49 Million |
-14.55% |
| 2021-12-31 | €14.50 Million ≈ $16.95 Million |
+11.00% |
| 2020-12-31 | €13.06 Million ≈ $15.27 Million |
-5.61% |
| 2019-12-31 | €13.84 Million ≈ $16.18 Million |
+99317.53% |
| 2018-12-31 | €13.92K ≈ $16.28K |
-35.49% |
| 2017-12-31 | €21.58K ≈ $25.23K |
-7.43% |
| 2016-12-31 | €23.31K ≈ $27.26K |
+64.93% |
| 2015-12-31 | €14.13K ≈ $16.53K |
-99.75% |
| 2014-12-31 | €5.55 Million ≈ $6.49 Million |
+148.31% |
| 2013-12-31 | €2.24 Million ≈ $2.61 Million |
+30.13% |
| 2012-12-31 | €1.72 Million ≈ $2.01 Million |
+36.50% |
| 2011-12-31 | €1.26 Million ≈ $1.47 Million |
-- |
About Amoeba SA
Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopath… Read more